Health and Healthcare

Bio-Path Holdings : BPTH

BPTH

Stock Data

$0.06

$0.01 (13.16%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Bio-Path Holdings, Inc. is an RNAi nanoparticle drug development company focused on preclinical and clinical stage oncology in the United States. The company is headquartered in Bellaire, Texas.

All Bio-Path Holdings Articles

3 Articles

Chris Lange | Mar 30, 2020 at 12:27 PM EDT

How Much Cash Can Bio-Path Burn?

Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way…

Paul Ausick | Mar 12, 2020 at 8:10 AM EDT

Are Limited Financing Options Punishing Bio-Path Stock?

Like all developmental drug companies, Bio-Path is betting on the success of its drug candidates. Drugs that are in trials…

Douglas A. McIntyre | Feb 18, 2020 at 10:55 AM EST

How Delayed Drug Approval Is Punishing Bio-Path Stock

What is it like to have a stock plunge 90% in less than a year and wipe out a huge…